PHCbi-Panasonic eBook - 24

Cell Therapy Production
Moves to Factory Floor
Assembly Lines Are Preparing to Churn out Safe,
Reliable, and Affordable Constructs
Meghaan M. Ferreira, Ph.D.

Emily survived a terminal diagnosis of relapsed
or refractory acute lymphoblastic leukemia (r/r
24

| GENengnews.com

The year 2017 marked a milestone not just
for Emily but for the cell therapy industry, as
the FDA approved its first CAR-T therapy and
Novartis launched Kymriah™ commercially.
According to Pascal Touchon, senior vice president and global head, cell and gene, Novartis
Oncology, "Delivering this therapy to patients

ADDITIONAL CONTENT

CPWS
cGMP-compliant cell therapy equipment for cell
therapy and regenerative stem cell processing
and manufacturing.
Learn More

4X-image/Getty Images

B

rown hair frames the face of a vibrant, rosycheeked girl who has two reasons to consider the day, May 10, 2017, a good day to celebrate. One reason is no more remarkable than
another birthday, her 12th. The other reason,
however, is worthy of all the news coverage it received. A chalkboard held by the girl, one Emily
Whitehead, said it all: "I am 5 years cancer free!"

ALL) after receiving CAR-T (chimeric antigen
receptor T-cell) therapy during Phase I trials
at the Children's Hospital of Philadelphia. Her
miraculous story has inspired hope and fortified
the campaign for cell therapies.

https://www.phchd.com/us/biomedical/cpc/cpws/cpws?utm_source=gen&utm_medium=ebook&utm_campaign=cpws PHCbi logo: https://www.phchd.com/us/biomedical/?utm_source=gen&utm_medium=ebook&utm_campaign=cpws https://www.phchd.com/us/biomedical/?utm_source=gen&utm_medium=ebook&utm_campaignHYPERLINK "https://www.phchd.com/us/biomedical/?utm_source=gen&utm_medium=ebook&utm_campaign=incubators http://www.GENengnews.com

PHCbi-Panasonic eBook

Table of Contents for the Digital Edition of PHCbi-Panasonic eBook